Is GRNA or FCPT a better dividend investment in 2026?

GRNA currently yields 667.78% with a 5% 5-year dividend growth rate. FCPT yields 6.05% with 5% growth. The better choice depends on your goal: GRNA offers higher current income.

What is the dividend yield difference between GRNA and FCPT?

GRNA has a forward dividend yield of 667.78% ($2.00/share annually). FCPT yields 6.05% ($1.43/share annually). The yield gap is 661.73 percentage points.

Home › Compare › GRNA vs FCPT

GRNA vs FCPT: Dividend Comparison 2026

GRNA yields 667.78% · FCPT yields 6.05%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GRNA wins by $616486.72M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GRNA

● Live price

667.78%

Share price

$0.30

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$616486.77M

Annual income

$476,205,667,861.38

Full GRNA calculator →

FCPT

● Live price

6.05%

Share price

$23.65

Annual div

$1.43

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.1K

Annual income

$5,775.28

Full FCPT calculator →

Portfolio growth — GRNA vs FCPT

📍 GRNA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GRNA	FCPT
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GRNA + FCPT cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GRNA pays

FCPT pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GRNA

Annual income on $10K today (after 15% tax)

$56,761.27/yr

After 10yr DRIP, annual income (after tax)

$404,774,817,682.17/yr

FCPT

Annual income on $10K today (after 15% tax)

$514.49/yr

After 10yr DRIP, annual income (after tax)

$4,908.99/yr

At 15% tax rate, GRNA beats the other by $404,774,812,773.19/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GRNA + FCPT for your $10,000?

GRNA: 50%FCPT: 50%

100% FCPT50/50100% GRNA

Portfolio after 10yr

$308243.41M

Annual income

$238,102,836,818.33/yr

Blended yield

77.25%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

GRNA

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$11.00

+3572.8% upside vs current

Range: $4.00 — $18.00

Altman Z

-9.5

Piotroski

2/9

FCPT

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$27.00

+14.2% upside vs current

Range: $25.00 — $29.00

Altman Z

1.4

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GRNA buys

FCPT buys

No recent congressional trades found for GRNA or FCPT in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGRNAFCPT

Forward yield	667.78% ✓	6.05%
Annual dividend / share	$2.00 ✓	$1.43
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$616486.77M ✓	$49.1K
Annual income after 10y	$476,205,667,861.38 ✓	$5,775.28
Total dividends collected	$605026.56M ✓	$24.1K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold
Analyst price target	$11.00	$27.00 ✓

Year-by-year: GRNA vs FCPT ($10,000, DRIP)

Year	GRNA Portfolio	GRNA Income/yr	FCPT Portfolio	FCPT Income/yr	Gap
1← crossover	$77,478	$66,777.96	$11,401	$700.92	+$66.1K → GRNA
2	$566,436	$483,534.63	$13,064	$864.84	+$553.4K → GRNA
3	$3,909,908	$3,303,820.95	$15,051	$1,072.48	+$3.89M → GRNA
4	$25,496,784	$21,313,183.41	$17,442	$1,337.22	+$25.48M → GRNA
5	$157,173,879	$129,892,319.14	$20,340	$1,677.08	+$157.15M → GRNA
6	$916,508,625	$748,332,575.36	$23,880	$2,116.57	+$916.48M → GRNA
7	$5,058,850,510	$4,078,186,281.00	$28,241	$2,689.36	+$5058.82M → GRNA
8	$26,450,685,234	$21,037,715,188.18	$33,660	$3,442.07	+$26450.65M → GRNA
9	$131,103,833,389	$102,801,600,188.27	$40,456	$4,439.95	+$131103.79M → GRNA
10	$616,486,769,587	$476,205,667,861.38	$49,063	$5,775.28	+$616486.72M → GRNA

GRNA vs FCPT: Complete Analysis 2026

GRNA — Stock

GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.

Full GRNA Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →

📬

Get this GRNA vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GRNA vs SCHD GRNA vs JEPI GRNA vs O GRNA vs KO GRNA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.